Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,843 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ADAM8 affects glioblastoma progression by regulating osteopontin-mediated angiogenesis.
Li Y, Guo S, Zhao K, Conrad C, Driescher C, Rothbart V, Schlomann U, Guerreiro H, Bopp MH, König A, Carl B, Pagenstecher A, Nimsky C, Bartsch JW. Li Y, et al. Among authors: zhao k. Biol Chem. 2020 Sep 11;402(2):195-206. doi: 10.1515/hsz-2020-0184. Print 2021 Jan 27. Biol Chem. 2020. PMID: 33544472 Free article.
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.
Güner G, Aßfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y, Slivinschi BI, Imhof A, Jocher G, Strohm L, Behrends C, Langosch D, Bronger H, Nimsky C, Bartsch JW, Riddell SR, Steiner H, Lichtenthaler SF. Güner G, et al. Among authors: zhao k. EMBO Mol Med. 2022 Oct 10;14(10):e16084. doi: 10.15252/emmm.202216084. Epub 2022 Sep 7. EMBO Mol Med. 2022. PMID: 36069059 Free PMC article.
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.
Cosenza-Contreras M, Schäfer A, Sing J, Cook L, Stillger MN, Chen CY, Villacorta Hidalgo J, Pinter N, Meyer L, Werner T, Bug D, Haberl Z, Kübeck O, Zhao K, Stei S, Gafencu AV, Ionita R, Brehar FM, Ferrer-Lozano J, Ribas G, Cerdá-Alberich L, Martí-Bonmatí L, Nimsky C, Van Straaten A, Biniossek ML, Föll M, Cabezas-Wallscheid N, Büscher J, Röst H, Arnoux A, Bartsch JW, Schilling O. Cosenza-Contreras M, et al. Among authors: zhao k. Neuro Oncol. 2024 Mar 4;26(3):488-502. doi: 10.1093/neuonc/noad208. Neuro Oncol. 2024. PMID: 37882631 Free PMC article.
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.
Zhao K, Braun M, Meyer L, Otte K, Raifer H, Helmprobst F, Möschl V, Pagenstecher A, Urban H, Ronellenfitsch MW, Steinbach JP, Pesek J, Watzer B, Nockher WA, Taudte RV, Neubauer A, Nimsky C, Bartsch JW, Rusch T. Zhao K, et al. Cells. 2024 Apr 4;13(7):632. doi: 10.3390/cells13070632. Cells. 2024. PMID: 38607071 Free PMC article.
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis.
Gao Y, Zandieh K, Zhao K, Khizanishvili N, Fazio PD, Yu X, Schulte L, Aillaud M, Chung HR, Ball Z, Meixner M, Bauer UM, Bartsch DK, Buchholz M, Lauth M, Nimsky C, Cook L, Bartsch JW. Gao Y, et al. Among authors: zhao k. Cell Oncol (Dordr). 2024 Oct 16. doi: 10.1007/s13402-024-01001-0. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 39412616
Tumor and Blood B Cell Abundance Outperforms Established Immune Checkpoint Blockade Response Prediction Signatures in Head and Neck Cancer.
Chang TG, Spathis A, Schäffer AA, Gavrielatou N, Kuo F, Jia D, Mukherjee S, Sievers C, Economopoulou P, Anastasiou M, Moutafi M, Pal LR, Vos J, Lee AS, Lam S, Zhao K, Jiang P, Allen CT, Foukas P, Gomatou G, Altan-Bonnet G, Morris LGT, Psyrri A, Ruppin E. Chang TG, et al. Ann Oncol. 2024 Nov 15:S0923-7534(24)04914-7. doi: 10.1016/j.annonc.2024.11.008. Online ahead of print. Ann Oncol. 2024. PMID: 39551185
7,843 results